Skip to Main Content

Paper Details

NRG1 fusions in breast cancer.
Breast Cancer Res
17
2021
ARHGEF39, DOC4, DOC4(TENM4)-NRG1 fusion, ERBB2, ERBB3, FAM91A1, GAB2, HER2, MDA-MB-, MDA-MB-175, MRPL48, NRG1, NRG1 fusion, NRG1 fusions, NRG1 gene, NRG1 gene fusions, PPP6R3, RSF1, TENM4, TPCN2, WRN, ZNF704, breast cancer, breast cancer cell line MDA-MB-175, breast cancers, cancers, expressed gene fusions, fusion transcripts, nuclear-localised form, patient, receptor tyrosine kinase, tyrosine, tyrosine kinase
Author NameAffiliation
Susanna L CookeHutchison-MRC Research Centre, University of Cambridge
Susanna L CookeUniversity of Cambridge
Susanna L CookePresent addresses: Wolfson Wohl Cancer Research Centre
Ernest TurroUniversity of Cambridge
Ernest TurroPresent addresses: Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai
Ernest TurroUniversity of Cambridge
Ernest TurroPresent addresses: Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai
Matthew D EldridgeCancer Research UK Cambridge Institute and Cancer Centre, University of Cambridge
Oscar M RuedaCancer Research UK Cambridge Institute and Cancer Centre, University of Cambridge
Oscar M RuedaUniversity of Cambridge
Carlos CaldasCancer Research UK Cambridge Institute and Cancer Centre, University of Cambridge
Carlos CaldasCambridge Breast Cancer Research Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust
  • 1 - 12

Datasets

Release 1.2